According to 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, the BNP and NT-proBNP plasma concentrations should be considered to contribute to patient’s prognosis (death, acute heart failure) [7]. The gene discussed is NPPB; the disease is acute coronary syndrome.